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1. Introduction 
In last 15 years the use of probiotics strains in animal production has been increased. These 
probiotics strains can modulate the balance and activities of the gastrointestinal microbiota 
in which are responsible to gut homeostasis. The intake of probiotics supplemented in ration 
and provided to the animals, can strongly affect the structure and activities of the gut 
microbial communities leading to promoting health and improving the performance in 
livestock, when it is impaired by numerous factors, such as dietary and management 
constraints. The understanding of the digestive ecosystems in terms of microbial 
composition and functional diversity is fundamental to modulate the gastrointestinal tract 
(GIT) of domestic animals providing to them the possibility to maintain the homeostasis of 
these complex microbial communities, which can be composed of bacteria, protozoa, fungi, 
archaea, and viruses, thus promoting a reduction of the incidence of diseases. Therefore 
considerable researchs during 30 years are characterizing the domestic animals ´GIT. The 
welfare, health and feed efficiency of the animals can be affected by different factors, many 
of them, environmental factors. Among these factors, feeding practices, composition of 
animal diets, farms management and productivity constraints can influence the microbial 
balance in GIT, whose role is fundamental to gut homeostasis and its reduction 
consequently can affect efficiency digestive When occurs the reduction of microbial in GIT, 
some reactions as digestion and fermentation of plant polymers are impaired, since the 
action of the microbiota on gut is strongly related with the realization these reactions, and 
the animals also are impaired by the fact these polymers to be of particular importance to 
the herbivorous (Chaucheyras-Durand and Durand, 2010). 
2. Use of antibiotics 
The problem caused by indiscriminate use of antibiotic as growth promoter in feed to 
livestock is that this practice has been associated with emergence of resistance to antibiotics 
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in zoonotic bacteria. The use of growth promoter in feed to livestock has been done since 
1940 because this practice is correlated with higher health status and improves at 
performance of animals in terms of feed conversion. The use of antibiotics at animal has had 
a profound impact on animal health and welfare.  
The problems found by this practice require the development of alternative intervention 
strategies for zoonotic livestock pathogens. Some these strategies could be vaccines in 
diarrhea in neonates and post weaning animals, limited access to livestock, control of 
vermin, modifying air flow, high level disinfection regimes, acidification of feed and the 
supply of probiotic into animals supplemented in ration by example are efficient 
management to reduce the occurrence of pathogen at the animal production. 
3. Use of probiotics strains 
All additives used in animal feed, including yeasts and bacteria, are strictly regulated within 
the EU legislative framework. Until May 2003, the risk assessment of animal feed additives 
for use in European was the responsibility of the Scientific Commitee of Animal Nutrition 
(SCAN) (Anadon et al., 2006). After this date, the European Food Safety Authority (EFSA) 
took over the functions of SCAN. While EFSA provide expert scientific advice to the 
European Commission the approval and risk management of a probiotic product is 
responsibility of the EC and its constituent member’s states. For use of microorganism in 
United States as a feed additive is necessary before the product to be outgoing to approval 
by the Food and Drug Administration (FDA). 
The requirements for a novel probiotic product required by EU regulations on animal feed 
additives are the identification and characterization to species level, and the efficacy data 
must be provided in support of any claims made for the product. Some characteristics are 
requested to product such as no adverse effects on the health of performance, the product 
must be safe for the operator, have no adverse effects upon exposure and also the product 
must not pose a risk to the safety of the end-consumer (SCAN, 2001). 
4. Use of probiotics to control gastrointestinal diseases in livestock 
The intensive production farmed livestock together with the veto of the use of antimicrobial 
feed supplements in the EU, this situation has increased the risk of contracting 
gastrointestinal diseases if prophylactic antimicrobial feed supplements are not utilized. The 
removal of growth promoters has led to a significant increase in the incidence of diseases 
and also with significant increases in feed costs, the reduced feed weight conversion. 
5. Use of probiotics in animals 
Although the mechanisms involved have not been fully elucidated a reduction in pathogen 
carriage and subsequent clinical disease is one possible mechanisms responsible by 
reduction of occurrence of disease when the growth promoter is utilized in livestock. After 
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this prohibition many problems arisen and also the need of use of alternatives to resolve this 
situation. One of these alternatives is the use of probiotics as feed supplement or functional 
food which may be used for prophylaxis in animals and humans. There are numerous 
probiotics products commercially available for livestock. Currently commercial livestock 
probiotic can be separated into two categories, being these, competitive exclusion that are 
defined and those that are undefined. 
6. Use of probiotic in ruminants 
In ruminants that have four stomachs being them rumen, omasum, reticle and abomasums 
when these animals born they have the abomasums extremely big. This situation occurs 
because the type of food is liquids as milk. Usually the animal becomes ruminants when he 
from the third or fourth month of age. This development is due the installation of 
microbiota ruminal in gut and also by distention of organ due the fiber intake. The bacteria 
from rumen and bowel are acquired through the contact of cattle with the cow or other 
animal and also by grass intake. 
The rumen is as fermentation chamber and it has approximately for 50-85% by use of dry 
matter from food. The saliva is mixed with food and has a control upon pH of rumen and 
the papillae existing in inner wall of the rumen increasing the absorption area. 
The amount of bacteria from rumen is the approximately 1011 CFU/g of counts rumen, the fungi 
is the 103 CFU/g and the protozoa is 105 cell /g. There are most of 60 species of bacteria that grow 
into rumen microbita and this environment has CO2, CH4 and N2 stomach gas maintaining the 
pH value among 6 – 6.5. The temperature within the rumen is 39ºC and the bacteria type living 
can be characterized according to theirs functions such as cellulolytic, proteolytic, amylolytic. 
 
Picture 1. Picture took from Antibiotics and chemotherapeutic and probiotics  
Avila et al Funep Publisher Brazil 83p. 
The proteins and fibrous foods in rumen are converted at ammonia, organic acids and 
amino acids by microorganism’s action. As the majority of amino acids are synthesized of 
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rumen the animals need to be supplied with essential amino acids from ration or injectable. 
The main factors of stress feed that leaving to a decreasing of ruminal microbiota are dry 
grasslands, pastures in budding and seasonal changes. The decreasing of ruminal 
microbiota can be caused by antibiotics use and also environment changes as occur at 
auctions, expositions and pre-slaughter. The use of rumen bacteria into ruminants promotes 
the growth into gut before the establishment of pathogen in these animals causing the 
prevention of diarrhea occurrence. This situation decreases the weaning time and maintains 
the balance of rumen microbiota increasing the production of enzymes as cellulase, amylase, 
urease, protease consequently increasing improving the use fibrous foods. Others benefits to 
use of probiotics in ruminants are promotes the increasing of weight gain, increasing the 
milk production and decreasing of diarrhea period. 
 
Picture 2. Picture took from Antibiotics and chemotherapeutic and probiotics Avila et al Funep 
Publisher Brazil 83p. 
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The advantages of the use of probiotics in livestock are the period of adaptation of animal is 
not necessary, doesn´t hinder the management on the farm because it can be supplement to 
ration or mineral salt, and as probiotic is the natural product does not necessary the disposal 
of milk and also this product can be used during the slaughter of animals as cattle, sheep 
and buffaloes. According with FERREIRA, (2003) the probiotics microorganisms most used 
belong to the group of lactic bacteria as Aerococcus, Atopobium, Bifidobacteirum, Brochothrix, 
Carnobacterium, Enterococcus, Lactobacillus, Weissella. The lactic bacteria are positive Gram, 
anaerobic, negative catalase, presenting of cocos and bacillus way. The probiotics can counts 
ruminal bacterias as Ruminobacter and Succinovibrio with specifics characteristics that are 
used in supplementation of ruminants.  
Some authors have been showed that some probiotics strains have seen resistant to the 
antibiotics effects and therefore these strains could be used together the administration of 
antibiotics in animals. The yeasts are unicellular microorganisms with capacity of survive in 
several mediums have a great spectrum of pH and many mediums can be saline or without 
oxygen. The Saccharomyces boulardii has been largely tested in human’s trials (PENNA et al., 
2000). And the Saccharomyces cerevisiae in animals showed promising results. 
The Lactobacillus is constituted by cells that vary long and thin to short and curves with 1.5-
6.0µm length and 0.6-0.9 width. The ideal temperature to growth is 45ºC and grows in pH 
5.5-6.0. The Lactobacillus species known at moment is 56 and the most used as additive are 
L. acidophilus, L. rhamnnosis and L. casei.  
 
Picture 3. Picture took from Antibiotics and chemotherapeutic and probiotics Avila et al Funep 
Publisher Brazil 83p. 
The genus Bifidobacterium includes 30 species. Many of these 10 are form humans dental 
caries, vagina and feces, 17 are from animal origin 2 are from wastewater and 1 of fermented 
milk. These bacteria present optimal growth among 37ºC and 41ºC and minimal growth 
among 25º C and 28ºC at pH 6-7. The Bifidobacterium Bifidobacterium animallis, Bifidobacterium 
lactis, Bifidobacterium longum species have probiotics characteristics also have capabilities to 
ferment complex carbon. 
Some species of Bacillus subtilis, Bacillus licheniformis and Bacillus cereus are bacteria positive 
Gram in rods form. The Bacillus are the only that form spores allowing that these strains to 
be used in adverse conditions mainly in high temperature. 
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Picture 4. Picture took from Antibiotics and chemotherapeutic and probiotics Avila et al Funep 
Publisher Brazil 83p. 
 
Picture 5. Picture took from Antibiotics and chemotherapeutic and probiotics Avila et al Funep 
Publisher Brazil 83p. 
Enterococcus faecium is the microorganism belonged to the Enterococcus genus belonged to the 
Lancifield D group. This morphology identification requests the use of coloration by Gram 
and also catalase test in blade. These bacteria are positive Gram and present the characteristic 
form of streptococcus (chain cocos), negative catalase and no spore and faculty anaerobic. 
Through the chemical analysis the strain ferment the lactose, arabinose, mannitol, no ferment 
the sorbitol. This strain growth into MacConkey medium containing 6.5% of NaCl. 
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Picture 6. Picture took from Antibiotics and chemotherapeutic and probiotics Avila et al Funep 
Publisher Brazil 83p. 
Ruminobacter amylophilum is the microorganism belonged to the Ruminobacter genus to its 
morphology identification is necessary to use Gram coloration this genus present as rods 
negative Gram. They have motility and no spores. This ferments the cornflour, maltose and 
liquefy gelatin. They synthesize lactic acid and CO2 from formic acid.  
7. Others benefits and action mode of probiotics strains 
7.1. Immune modulation 
The maturation of the humoral immune mechanisms can be conducted by microbial 
colonization, this events can promote the c circulation of the IgA and IgM secreting cells. 
The other important factor that can be affected by microbial colonization on the gut of 
different animals particularly the ruminants are the balance of the different T helper subsets. 
The memory B and T cells migrate to effectors sites in consequence these events. 
Other mechanisms to immune modulation are followed by active proliferation local induction 
of certain cytokines and production of secretion antibodies as IgA. When the host is exposure 
to the antigen, immune cells respond releasing cytokines from host direct the subsequent 
immune responses. The low-dose tolerance immunity TGF-B associated in via local cytokine is 
the man mechanisms which the gut associated lymphoid tissue maintains homeostasis. Some 
lactic acid bacteria can induces the production of proinflammatory cytokines, tumor necrosis 
factors alpha and interleukin-6 from human peripheral blood mononuclear cells. A strain of 
Lactobacillus casei can inhibit the growth of pathogenic strains as Pseudomonas aeruginosa and 
Listeria monocytogenes leading to an increase in the level of macrophages. Others strains as 
Lactobacillus acidophilus and Bifidobacterium bifidum could inhance non-specific immunity and 
concluded that specific lactic acid bacteria could play a role in specific age groups, specific 
neonates or the elderly. The results can be observed when two groups of animals are 
compared itself in relation with their age. Usually the positive effect against the colonization 
by pathogenic bacteria upon the gut occurs most efficiently in neonates than oldest. 
Some studies showed a significant increase in IgA immune response. In others, on children 
with mild to moderate stable Crohn´s Diseases, administration with strain GG improved the 
gut barrier function and clinical status after six months of therapy. 
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8. Antitumor activity 
Some probiotic strains could decrease some enzymes synthesized by many microorganisms 
may convert procarcinogens into carcinogens and cause colon cancer, some of them 
azoreductase, β- glucuronidase and nitroreductase. Lactobacillus acidophilus could decrease 
nitroreductase, azoreductase and β glucuronidase activities in carnivorous animals. Another 
strain as Lactobacillus rhamnosus could bacterial β-glucuronidase activity in the large 
intestine. 
Lactobacillus and Lactobacillus bulgaricus suppressed Ehrlich ascitis tumor or Sarcoma 180 in 
mice. Tumor suppression in associated with intact viable cells, intact dead cells and cell wall 
fragments or Lactobacilli and Bifidobacteria. When Lactobaacillus casei was provided into rats 
it had effective prevention against the recurrence of superficial bladder cancer. 
Nitites used in food processing are converted to carcinogenic nitrosamines in the 
gastrointestinal tract in several people. Cellular uptake of nitites by Lactobacillus and 
Bifidobacteria has been shown in vivo. Also, Lactobacillus has been shown as a great reducer 
of bile salts. They are implicated in the initiation of colon carcinogens. These strains have 
been biotransformed of primary to secondary bile salts, this way, there are reduction the 
possible initiation of cancer. Other authors have been suggested that the decrease of 
intestinal pH, through metabolic activities of Lactobacillus acid bacteria, could inhibit the 
growth of putrefactive bacteria, can prevent large bowel cancer. 
Many probiotics strains have a positive effect against mould growth and aflatoxin 
production. These aflatoxins are associated to cause cancer. Thus the reduction of these 
moulds decrease the occurrence of cancer caused by this mould. 
9. Reduction of cholesterol 
Some studies have showed the effect of fermented milk or milk containing probiotic strains 
producing lactic acid on serum cholesterol levels. These studies reported that a strain of 
Streptococcus thermophilus and Lactobacillus acidophilus reduced cholesterol levels in rats. Milk 
fermented with lactic acid bacteria and Streptococcus cerevisae led to lower serum cholesterol 
than control group, also phospholipids and bile acids in the fecal samples from mice were 
lower. When a trial was using rats inoculated with E. faecium , they presented a lower 
cholesterol levels. The same findings were observed in pigs that have been fed a high 
cholesterol diet. 
Another results also, showed that the serum lipoprotein levels of 334 individuals remained 
unchanged when they were treated with Lactobacillus acidophilus and L. delbrueckii subsp 
bulgaricus and E. faecium administered over six weeks to adults and it resulted in a initial 
increase in total cholesterol and LDL followed by a sharp decrease two weeks after 
termination of treatment. The decrease corresponded with an increase in the reduction of 
iodonitrotetrazolium and superoxide production by peripheral neutrophils and an elevated 
production of IgG. Several studies don´t explain because there was the reduction in 
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cholesterol levels and suggest that the reduction of cholesterol is not due to assimilation or 
to a direct interaction between the bacteria and cholesterol. This effect is due to the co-
precipitation of cholesterol with deconjugated bile salts at pH value below 6.0. This would 
not explain the reduction of cholesterol in vivo as the pH of the bower gastrointestinal is 
neutral to alkaline. Probably there is a physical association between cholesterol and the cell 
surface. 
10. Decreasing of lactose intolerance 
Some descents from Asia and Africa usually are stricken by lack the intestinal mucosal 
enzyme β-galactosidase and therefore suffer from reduction in lactase activity. This situation 
can occur many times after an infection caused rotavirus gastroenteritis. There are much 
lactic bacteria which are capable to synthesize the enzyme β-galactosidase. Many of them as 
the bacteria Streptococcus salivarius subps thermophilus and Lactobacillus delbrueckii subps 
bulgaricus. The levels of enzyme produced by these bacteria are high and many products 
treated with this enzyme presented a low concentration of lactose. These species are 
sensitive to bile salts. These substances can lead to release of high levels of β-galactosidase 
in the gastrointestinal tract. Lactose from fermented milk containing the probiotic 
Lactobacillus acidophilus were better absorbed by many people with lower β-galactosidase 
activity. All symptoms from lactose intolerance were decreased. 
11. Stool transit  
The diarrhea occurrences in neonate are the main cause of death. This disorder affects 
animals of many species and also the human among them the children. Lactobacillus GG had 
a high decreasing in severity of acute watery diarrhea in young children. Patients treated on 
erythromycin reacted decreasing the period of diarrhea when they received Lactobacillus GG. 
The symptoms caused by slow stool transit are diarrhea, stomach pain, abdominal pain and 
nausea. All symptoms were recovery quickly when the patients received Lactobacillus GG. 
Indeed one of the most severe diarrhea is that caused by Clostridum difficile. Usually people 
stricken by this disease recently passed by treatment with antibiotics. The supply of 
Lactobacillus rhamnosus improved the symptoms of intestinal disorders. 
 Patients who consumed milk fermented by the strain experienced less diarrhea than those 
that don´t received. Many of them were patients that were being treated with pelvic 
radiotherapy. The effect of different LAB n different types of diarrhea has been showed in 
many studies. Yet are needed others studies to determine which mechanisms the LAB use to 
relieve diarrhea. 
From now on this chapter will present some findings from some trials that were performed 
with the aim of verifying the protective effect of a probiotic mix that was kindly donated by 
IMEVE Biotecnology located in Jaboticabal São Paulo State against the colonization caused 
by STEC in sheep. 
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Abstract: Shiga toxin-producing Escherichia coli (STEC) strains are food-borne pathogens 
that cause human diseases, and ruminants are usually important reservoirs of STEC. The 
first step of enteric infection is colonization of the host’s gut mucosal surface by pathogenic 
strains of bacteria. Probiotic bacteria can decrease the severity of infection by competing for 
receptors and nutrients and by synthesizing an acid that creates an unfavorable 
environment for the growth of several bacterial species. The aim of this study was to 
determine whether the inoculation of sheep with a mixture containing 5 x 108 (CFU) of 
Lactobacillus acidophilus, Lactobacillus helveticus, Lactobacillus bulgaricus, Lactobacillus lactis, 
Streptococcus thermophilus and Enterococcus faecium per animal decreases the shedding at 
animals previously inoculated with STEC nonO157. Sheep that received oral inoculums 
containing 2 × 109 viable bacteria of STEC carriers of stx1, stx2 and eae genes were compared 
with others groups that did not receive inoculums. When probiotic was inoculated together 
with the STEC non-O157, the numbers of these same bacteria in a fecal sample were lower 
than the group did not receive. It occurred during the 3th, 5th, 6th and 7th weeks post-
inoculation. Thus, we conclude that this mixture likely presented a potential protective 
effect in reducing colonization by STEC non-O157 and can be used as an alternative method 
to decreases STEC non-157 infection in sheep, thereby reducing transmission to humans. 
12. STEC diseases 
Healthy cattle, sheep and other ruminants can be reservoirs of Shiga-toxin-producing 
Escherichia coli (STEC) strains. STEC have been associated with human diseases such as 
hemorrhagic colitis and hemolytic uremic syndrome (Hussein 2007; Ramamurthy 2008). 
These bacteria can be transmitted from person to person (Belongia et al., 1993), but most 
outbreaks have been associated with the consumption contaminated beef products or a 
variety of other foods. Before colonization by STEC, it may be possible to determine whether 
to use the colonization of ruminal mucosa by oral administration of probiotic bacteria as a 
strategy (Ávila et al., 2000). 
Probiotics are live microorganisms that, when administered in the appropriate amount, will 
benefit the health of the host (Food and Agriculture Organization of the United Nations, 
2003; Sanders, 2003). Microbial interference is common to all genera and decreases the 
severity of infection by mechanisms involving nutrient competition, generation of an 
unfavorable environment, and competition for attachment or adhesion sites (Chaucheryras-
Durand and Durand, 2010). Probiotics bacteria can stimulate the immune system through 
innate cell surface pattern recognition receptors or via direct lymphoid cell activation. 
Practical applications for this action of probiotics based on this characteristic include their 
use in anti-tumor, anti-allergy and immunotherapy treatments, but there is also increasing 
evidence that some probiotics can sufficiently stimulate a protective immune response to 
enhance resistance to microbial pathogens (Cross, 2002). 
The benefits caused for use of probiotics strains in ruminants are known, however there are 
few information about the use of probiotics strains to reduction of shedding of STEC non-
O157 in sheep.  
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This study verified the protective effect of probiotic treatment against the colonization of 
STEC non-O157 in sheep measured the number of STEC recovered from fecal simple. 
13. Materials and methods 
13.1. Animals and experimental locations 
The study was performed with 20 sheep of Santa Ines race in the fattening stage, female 
previously screened by not be carrying of STEC non-O157 strains distributed in four groups 
with five animals each that were confined at a property located in São Paulo State. The 
experiment was made January to March 2012. The sheep were selected based on closeness of 
body weight (41 ± 2) kg and age (9-12) months. Then, all animals were ear-tagged and 
drenched with Ivomec (MSD- Agvet Merck) for internal parasite control at the rate of 2cc/46kg 
body weight. During three weeks pre-experimental adaptation period, were offered for all 
groups of sheep a diet of identical composition ad libitum consumption. Group I did not 
receive the probiotics strains or STEC non-O157 being the control group. Group II received an 
only oral dose of inoculums containing 2 x 109 viable cell of STEC non-O157 per animal. Group 
III received an only oral dose of inoculums containing 2 x 109 viable cell of STEC non-O157 per 
animal together with daily oral doses at concentration of 5 x 108 CFU of Lactobacillus 
acidophilus, Lactobacillus helveticus, Lactobacillus bulgaricus, Lactobacillus lactis, Streptococcus 
thermophilus and Enterococcus faecium per animal lyophilized provided directly in the mouth of 
animals with help of a cannula of application throughout the experiment. The inoculums were 
provided with help of a cannula of application and were diluted at 40mL of 0.9% saline 
solution. Group IV received the probiotics alone at the same number of cells viable and of the 
same way. During three weeks before of start of experiment always in same hour in the 
morning were collected feces samples directly of rectum of these animals. The samples were 
cultured in plate on MacConkey agar then the colonies that grew had their DNA extracted as 
described by Wani et al. (2003) to verify the absence of STEC non-O157 and Salmonella. After 
the third week the groups of animals were inoculated and monitored by seven weeks with 
weekly collections of their feces. All animals of present study were not carrying STEC non-
O157 before inoculation and were kept in bays separated to avoid cross contamination 
throughout the experiment in an environmentally controlled building. Each pen had a 
concrete floor with individual drain, a feeding box and water through and was cleaned once a 
day and the fecal material deposited was transported to other place where it was composted. 
This study was conducted in accordance with the ethical guidelines for investigations 
involving laboratory animals and was approved by the Ethics in Animal Research 
Committee (EARC) of UNESP-Univi Estadual Paulista and no adverse effects were observed 
in the animals receiving the E. coli (STEC) and probiotics during the experiment. 
14. Probiotic 
The probiotics bacteria used were Bacillus cereus, Lactobacillus acidophilus and Enterococcus 
faecium all strains in amount of 3 x 108 (CFU). These strains were isolated from sheep rumina 
and intestinal tracts following the recommendations of Hungate (1975) and Wolf et al. 
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(1975). These bacteria have the following features: they are nonpathogenic, enzyme-
producing and resistant to lactic acid and low pH. These strains were kindly donated by 
Imeve Medications Veterinary Industry responsible by all tests realized concerning the 
quality and conditions of use.  
15. STEC non-O157 
To verify the protective effect of probiotics strains reducing the shedding of STEC was used 
a STEC non-O157 strain isolated from healthy sheep and characterized as described by 
Possé et al., (2007). It was kindly donated by Laboratory of bacteriological from UNESP 
Jaboticabal. 
16. Samples 
For seven weeks, post-inoculation feces samples in same hour in the morning were collected 
from the sheep and transported to the laboratory, where DNA was extracted. Bacterial 
strains grown overnight in nutrient broth (Sigma) at 37º C were pelleted by centrifugation at 
12,000g for 1 min, resuspended in 200m L of sterile distilled water, and lysed by boiling for 
10min. Lysates were centrifuged as described above, and 150m L of the supernatants was 
used as DNA template for the PCR (Wani et al. , 2003). All isolates were subjected to PCR; 
stx1, stx2, and eae genes were detected using the primers and PCR conditions described by 
China et al. (1996). Control reference strains were E. coli EDL 933 (O157:H7, stx1, stx 2, eae) 
and E. coli K12 (negative control). 
17. STECs recuperated 
The values of STEC in each sample were determined of two different methods of counting. 
In both 1 g of each fecal sample was collected, cultured on MacConkey agar, then it was 
incubated at 37ºC for 24 h. In the first counting, all colonies grown displaying similar 
genome to STEC non-O157 strain previously inoculated orally were counted. In second 
counting were selected at least five colonies per sample grown and then separated in STEC 
non-O157 displaying pattern genome the others isolates from E. coli that did not display this 
specific DNA patterns.  
18. E. coli STEC fingerprint by pulsed-field gel electrophoresis (PFGE) of 
chromosomal DNA 
Genomic DNAs from STEC non-O157 isolates cultured from sheep were prepared as 
previously described by Barret et al., 1994. The agarose-embedded DNA was digested with 
10U of XbaI/plug (Gibco BRL) at 37ºC overnight. PFGE was performed in a CHEF-DR II unit 
(Bio-Rad Laboratories, Hercules, Calif.) using 1% PFGE grade Tris Borate EDTA buffer gels. 
The DNA was electrophoresed for 20 hours at a constant voltage of 200V (6V/cm) pulse time 
of 5 to 50 s, an electric field angle of 120° and a temperature of 15°C before being stained 
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with ethidium bromide. Resulting patterns were analyzed on a DNA Pro Scan, ProRFLP 
program (DNA Proscan, Inc. Nashville, Tenn), and the size of the DNA fragments was used 
as the criteria for categorizing distinct patterns. 
19. Results 
The animals received inoculums containing only one isolate of STEC non-O157 carriers of 
stx1, stx2 and eae genes. After three day post inoculations fecal samples were collected from 
these animals to make the re-isolating of the strains STEC non-O157 that had been 
previously inoculated into animals. All strains isolated from fecal samples had their DNA 
patterns compared with DNA pattern from STEC non-O-157 strain previously inoculated 
into animals and all those strains had the DNA similar to the strain previously inoculated 
were counted.  
From strains isolated from fecal simples collected during the three weeks prior to 
inoculation of animals no STEC strain had the similar DNA to the DNA pattern from strains 
of STEC non-O157 previously inoculated into animals. The results showed that the STEC 
non-O157 strain previously inoculated into animals was the only strain recovered 
displaying this specific pattern of DNA. All strains isolated from fecal sample from animals 
from group I and IV also had no similar DNA patterns to the strain previously inoculated 
into animals these strains were classified as non-STEC (Table1).  
 Group III Group IV 
Weeks without inoculation 
1 0.0 0.0 
2 0.0 0.0 
3 0.0 0.0 
Weeks post-inoculation   
1 34/134 0.0 
2 122/152 0.0 
3 133/143 0.0 
4 288/119 0.0 
5 323/123 0.0 
6 129/143 0.0 
7 84/138 0.0 
Table 1. Proportion of means of STEC with the means of ordinary E. coli grown on plate re-isolated 
from feces samples from sheep from Groups I to IV during three weeks without inoculation and then 
during seven weeks post-inoculation. 
Ordinary strain of E. coli were all strains that not displayed similar DNA to the strains 
previously inoculated into animals 
The relations among the means values of STEC non-O157 strains displaying the specific 
pattern of DNA previously inoculated with E. coli strains non-STEC from group II and III 
were respectively as follows: 21/123, 130/142, 146/135, 304/122, 352/132, 190/145 and 90/148; 
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34/134, 122/152, 133/143, 288/119, 323/123, 129/143 and 84/138 bacteria isolated per gram of 
feces. (Table1). The means values of STEC non-O157 strains displaying specific pattern of 
DNA previously inoculated in the animals from groups II and III were compared among 
itself within the same week to verify the possible reduction of isolates occurred in the 
animals from group III by administration of probiotics strains (Figure1). 
 
 
Figure 1. Comparison among the means of STEC from samples feces from Groups II and III. 
In each week the same letters show that the means not differs among them. 
Comparing the means values of isolates of STEC non-157 strains from group II with the 
means values of isolates of STEC non-O157 strains from Group III within the same weeks 
verified that the difference was statistically significant among them only the third, fifth, sixth 
and seventh week post animals´ inoculation (Figure1). There was lowest shedding of STEC 
non-O157 displaying similar DNA to the pattern of STEC non-O157 previously inoculated 
into animals belonged to the Group III than Group II, except in the first, second, and fourth 
week. The Group III had been received probiotic together with the STEC non-O157. 
When the quantification was made through the selection at least five colonies from fecal 
sample during seven weeks of 1 to 5 sheep the results were 24, 26, 29, 30 and 29 in the group 
II and 20, 15, 19, 18, 16 in the group III (Table.2 and Table.3). The results show that there was 
no isolating of STEC non-O157 from sheep before the inoculation of bacteria inoculated. The 
total number of isolates from animals from group III were lowest than from group II. 
However these values not differ statistically. The aim this second counting was to verify if 
the reduction of shedding of STEC non-O157 from group III compared with group II would 
be shown by other way. However, this last counting way did not show statistical difference 
among the isolates.  
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 Sheep1 Sheep2 Sheep3 Sheep4 Sheep5 
Weeks post-inoculation      
1 2 2 3 3 2 
2 2 3 5 5 4 
3 5 4 5 4 5 
4 5 5 5 5 5 
5 4 5 4 5 5 
6 3 4 3 4 4 
7 3 3 4 4 4 
Total 24 26 29 30 29 
Table 2. Total values of STEC re-isolated from feces sample selecting at least five colonies grown per 
samples from Group II. 
 Sheep1 Sheep2 Sheep3 Sheep4 Sheep5 
Weeks post-inoculation      
1 3 2 3 3 2 
2 3 2 3 2 2 
3 4 1 3 2 2 
4 3 3 2 3 3 
5 1 4 3 3 3 
6 4 2 3 2 3 
7 2 1 2 3 1 
Total 20 15 19 18 16 
Table 3. Total values of STEC re-isolated from feces sample selecting at least five colonies grown per 
samples from Group III. 
20. Discussion 
Shiga-toxin-producing E. coli (STEC) strains are associated as a foodborne pathogen since 
1982 and it has been identified as the cause of several outbreaks (Beutin et al., 2002; Karmali 
et al., 1989; Willshaw et al., 2001). 
Probiotics are live microorganisms taken as food supplements that beneficially affect the 
host, maintaining a balance in their intestinal microbiota (Fuller, 1989). The ruminants 
including cattle, sheep and deer are reservoirs of STEC and the fecal shedding of these 
bacteria forms the vehicle of entry into the human food chain (Lema et al., 2001). The 
probiotics could be used as strategies to reduction of shedding these pathogens by animals 
(Chaucheyras-Durand et al. 2010). 
In the present study we evaluated the protective effect of a mixture of probiotics strains to 
decrease the shedding of STEC non-O157 in sheep. The group III that received probiotic had 
fewer STEC non-O157 recovered from their feces when compared with the group II that did 
not receive the probiotics being that these differences were significant in 3th, 5th, 6th to 7th 
weeks. The probiotics strains failed to decrease the shedding of STEC non-O157 by feces 
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during the first, second and fourth week post inoculation. In last three weeks of experiment 
there was a reduction in the shedding of the STEC non-O157 from feces from group III that 
received probiotic together with STEC non-O157 compared with the shedding of the STEC 
non-O157 from feces from group II which received STEC non-O157 only. For unknown 
reason the shedding of STEC non-O157 from group III was lower than group II during the 
third week post inoculation. However in the fourth week post inoculation there was no 
difference among the number of isolates of STEC non-O157 from both group III and II. As 
the probiotics beneficially affect the host, maintaining a balance in their intestinal microbiota 
(Fuller, 1989) probably the presence of probiotics strains hindered colonization and 
consequently the shedding these bacteria by feces.  
Several mechanisms have been proposed to explain the beneficial effects of probiotics 
among them are the production of organic acids by bacterial probiotics can help decrease 
the gut pH, create more favorable ecological conditions for the resident microbiota and 
decrease the risk of pathogen colonization (Servin, 2004). The growth of pathogenic bacteria 
also can be hindered by synthesis of antimicrobial peptides, such as bacteriocins or 
production of enzymes able to hydrolyze bacterial toxins (Buts, 2004), stimulating the 
immune system, increasing the absorption of minerals and increasing the syntheses of 
vitamins (Thuory et al., 2003). Bactericins are produced by many lactic acid bacteria (LAB), 
including species normally found in the gastrointestinal tract as L. acidophilus-group as L. 
acidophilus, Lactobacillus amylovorus, L. crispatus, L. crispatus, Lactobacillus gallinarum, L. gasseri 
and L. plantarum, (De Vuyst et al., 1996 and Dicks & Botes, 2010). 
Chaucheyras-Durand et al. (2010) indicated that some strategies may be used in the rumen 
to decrease the number of viable STEC cells as the use of Lactobacillus acidophilus 
supplemented in the ration, thereby preventing the contamination of food. These strategies 
are the administration of probiotics in the ruminants. The impact of probiotics and the 
physicochemical conditions of the rumen digesta on the survival of pathogenic strains could 
have significant implications for farm management practices and food safety and decrease 
the risk of food-borne illness.  
In our study all sheep belonging to the group that received STEC non-O157 together with 
daily intake from probiotics strains had lower shedding this STEC non-O157. Some authors 
as Lema et al., (2001) verified that in lambs, the use of feed supplemented with lactic 
bacteria such as Lactobacillus acidophilus and Enterococcus faecium improved meat production. 
The mixture of probiotic strains used in this study contained strains of lactic bacteria, which 
probably allowed for the effect cited. Kritas et al., (2006) used Bacillus licheniformis and 
Bacillus subtilis supplemented in ration on sheep and verified although the mortality of 
sheep had not decreased there were beneficial effect on milk yields, fat and protein in milk. 
As many bacterial species are present in the intestine, and under normal conditions the 
majority of these bacteria are strictly anaerobic. This composition makes the gut capable of 
responding to the possible anatomic and physicochemical variations that occur (Lee et al., 
1999). The intestinal microbiota exercises a large influence on many biochemical reactions of 
the host. The balance maintained by probiotics hinders the growth of pathogenic 
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microorganisms that are present. In contrast, an imbalance in the gut microbiota may cause 
the proliferation of pathogens and subsequent bacterial infection (Gibson, 1998). 
The increased resistance against pathogens is the most important characteristic in 
developing effective probiotics. The use of probiotics strains excludes potentially pathogenic 
microorganisms and increases the natural defense mechanisms of the host (Puupponen-
Pimiä et al., 2002). The modulation of intestinal microbiota by probiotic microorganisms 
occurs through a mechanism of competitive exclusion (Guarner and Malagelada, 2003). 
Also, the probiotics help to reset the intestinal microbiota through adhesion and 
colonization of the intestinal mucosa. This action hinders the adhesion or invasion of 
epithelial cells by pathogenic bacteria and decreases the synthesis of toxin. An imbalanced 
microbiota causes changes, such as the diarrhea associated with infections or treatment with 
antibiotics, allergic reactions to foods, and intestinal inflammatory diseases. Therefore, 
correcting an imbalance in the intestinal microbiota constitutes the basis for probiotic 
therapy (Isolauri et al., 2004). According Zhao et al. (1998), probiotics administered prior to 
exposure to pathogenic E. coli may reduce the levels of pathogenic E. coli carried in most 
animals. In this study we observed that concurrent inoculation of probiotics strains with 
STEC strains probably hindered the colonization of the pathogenic bacteria in the sheep, as 
compared with the groups that did not receive the probiotics treatment as well as by 
consequence decreasing thus the shedding by STEC non-O157. According to Batista et al. 
(2008), the administration of Lactobacillus acidophilus, decreased the number of days the 
animals displayed symptoms of diarrhea in the group of ruminants that received the 
probiotic compared with the group that did not receive any probiotic. Roos et al., (2010) 
verify that the use of Bacillus cereus and Sacharomyces boulardii enhanced the humoral 
immune response of lambs to the vaccines.  
Some characteristics in probiotics strains are unwanted and much worrisome as well as 
antimicrobial resistance. Some lactic bacteria could present antibiotic resistance and these 
bacteria used for food is considered a major danger since this resistance could be transferred 
to pathogenic bacteria. The probiotics strains used in our study were tested to susceptibility 
to 27 antibiotics and verified that generally the Lactobacillus strains were inhibited to all 
antibiotics tested (Karapetkov et al., 2011). 
In a study with cattle performed in Brazil, the authors used a probiotic contained strains of 
Ruminobacter amylophilus, Ruminobacter succinogenes, Succinovibrio dextrinosolvens, Bacillus 
cereus, Lactobacillus acidophilus and Streptococcus faecium, and these strains were administered 
at a dose of 3 x 108 live cells (CFU) of each strain resuspended in 250 mL of milk and 
administered orally. This study had many groups of animals. Some animals were 
vaccinated, others received probiotic and others both were vaccinated and received 
probiotic. These results showed that the combination of vaccine with the probiotic 
administered for 15 or 30 days were the most effective treatments for the control of diarrhea 
and weight gain (Ávila et al., 2000). 
Some studies have indicated a higher prevalence of STEC in sheep than in cattle (Beutin et 
al., 1997; Sidjalat and Bensink, 1997; Urdahl et al., 2003), confirming that sheep are a 
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significant reservoir of STEC. The findings of this study suggest that this probiotic likely 
presented a potential protective effect in reducing colonization by STEC non-O157 and can 
be used as an alternative method to decrease STEC non-157 infection in sheep, thereby 
reducing transmission to humans. Probiotic microorganisms, which benefit from a “natural 
image”, can expect a promising future in animal nutrition (Chaucheyras-Durand and 
Durand, 2010). 
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